BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12861482)

  • 21. Duloxetine Eli Lilly & Co.
    Pitsikas N
    Curr Opin Investig Drugs; 2000 Sep; 1(1):116-21. PubMed ID: 11249587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral heparin (Emisphere).
    Dunn A
    IDrugs; 2000 Jul; 3(7):817-24. PubMed ID: 16080057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZD-1839 (AstraZeneca).
    Norman P
    Curr Opin Investig Drugs; 2001 Mar; 2(3):428-34. PubMed ID: 11575718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pexelizumab Alexion.
    Whiss PA
    Curr Opin Investig Drugs; 2002 Jun; 3(6):870-7. PubMed ID: 12137406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCI-779 Wyeth.
    Elit L
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1249-53. PubMed ID: 12211424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endostatin (EntreMed).
    Grosios K
    IDrugs; 2000 Jul; 3(7):799-810. PubMed ID: 16080055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rasagiline. Teva Pharmaceutical.
    Kupsch A
    Curr Opin Investig Drugs; 2002 May; 3(5):794-7. PubMed ID: 12090555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DP-VPA D-Pharm.
    Labiner DM
    Curr Opin Investig Drugs; 2002 Jun; 3(6):921-3. PubMed ID: 12137414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GL-701 Genelabs.
    Norman P
    Curr Opin Investig Drugs; 2001 Feb; 2(2):231-6. PubMed ID: 11816836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parecoxib. Pharmacia corp.
    Gotta AW
    IDrugs; 2001 Aug; 4(8):939-44. PubMed ID: 15973593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abarelix: abarelix-depot-F, abarelix-depot-M, abarelix-L, PPI 149, R 3827.
    Drugs R D; 2003; 4(3):161-6. PubMed ID: 12757402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fosamprenavir. Vertex Pharmaceuticals/GlaxoSmithKline.
    Corbett AH; Kashuba AD
    Curr Opin Investig Drugs; 2002 Mar; 3(3):384-90. PubMed ID: 12054084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nefiracetam. Daiichi Seiyaku.
    Crespi F
    Curr Opin Investig Drugs; 2002 May; 3(5):788-93. PubMed ID: 12090554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remune. Immune Response.
    Lai D; Jones T
    Curr Opin Investig Drugs; 2002 Mar; 3(3):391-8. PubMed ID: 12054085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Everolimus. Novartis.
    Dumont FJ
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1220-34. PubMed ID: 11717808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABI 007.
    Drugs R D; 2004; 5(3):155-9. PubMed ID: 15139776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eculizumab (Alexion).
    Kaplan M
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1017-23. PubMed ID: 12186261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zanamivir (Glaxo Wellcome).
    Oxford JS
    IDrugs; 2000 Apr; 3(4):447-59. PubMed ID: 16100701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BMS-275291. Bristol-Myers Squibb.
    Poulaki V
    Curr Opin Investig Drugs; 2002 Mar; 3(3):500-4. PubMed ID: 12054103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BIO-1211 (Biogen).
    Bolger GT
    IDrugs; 2000 May; 3(5):536-40. PubMed ID: 16100687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.